AI In Animal Health Market Size, Share and Growth Outlook, 2026

AI In Animal Health Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global AI In Animal Health Market size is forecast to increase from $2.6 Billion in 2026 to $8.82 Billion in 2034 at a CAGR of 16.5% between 2026 and 2034.

The AI In Animal Health market report provides detailed analysis and outlook of AI In Animal Health segments including By Component (Hardware, Software, Services ), By Application (Diagnostics & Pathology, Identification, Tracking & Behavior Monitoring, Predictive Health Analytics & Disease Forecasting, Veterinary Practice Management & Telehealth), By Animal Type (Companion Animals, Production / Livestock Animals ), By End-User (Veterinary Hospitals & Referral Centers, Private Veterinary Clinics, Commercial Farms & Livestock Producers, Academic & Research Institutions) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

AI in Animal Health Industry Overview

The AI in Animal Health industry is experiencing rapid growth as veterinary clinics, diagnostic laboratories, animal health companies, and livestock management organizations increasingly adopt artificial intelligence to improve diagnostic accuracy, clinical efficiency, and customer engagement. AI-powered technologies are transforming veterinary medicine by automating routine tasks, enhancing point-of-care diagnostics, and streamlining communication between animal health professionals and pet owners. The growing integration of machine learning, automated analytics, and intelligent workflow platforms is enabling veterinary practices to deliver faster and more data-driven care.

AI-Powered Point-of-Care Diagnostics Enhancing Veterinary Care

One of the most significant trends in the industry is the expansion of AI-enabled diagnostic platforms designed to accelerate clinical decision-making. Solutions such as Zoetis VETSCAN Imagyst have become increasingly central to veterinary workflows by automating fecal parasite identification and cytology pattern recognition. These technologies significantly reduce the time required for microscopic analysis while enabling clinics to provide same-day diagnostic results for common animal health conditions. Further strengthening this trend, Zoetis expanded the capabilities of its Vetscan OptiCell™ AI-powered hematology analyzer by introducing Cellular Hemoglobin Concentration Mean and plateletcrit parameters. These additions allow veterinarians to obtain advanced complete blood count insights at the point of care, bringing reference laboratory-level diagnostic capabilities directly into clinical settings.

Automation of Veterinary Documentation Improving Productivity

Administrative efficiency has emerged as another major area of AI adoption within veterinary healthcare. Veterinary practices are increasingly implementing AI-powered documentation tools that automate medical record creation and clinical note generation. Platforms such as PawfectNotes process audio captured during patient consultations and automatically generate structured SOAP notes and discharge summaries. By reducing the time spent on manual documentation, these solutions help veterinarians focus more on patient care while minimizing after-hours administrative workloads. The growing use of ambient AI documentation technologies reflects the industry's broader emphasis on workflow optimization and clinician productivity enhancement.

AI-Driven Customer Engagement Strengthening Industry Connectivity

Artificial intelligence is also transforming how animal health companies engage with veterinarians, pet owners, and livestock producers. Merck Animal Health selected Salesforce’s Agentforce Life Sciences platform to create a unified customer engagement environment powered by AI agents. The platform is designed to provide comprehensive support experiences across multiple communication channels, enabling more personalized interactions and streamlined service delivery. As animal health organizations continue investing in intelligent engagement technologies, AI-driven communication platforms are becoming increasingly important for improving stakeholder relationships, enhancing service responsiveness, and supporting more connected animal healthcare ecosystems.

AI In Animal Health Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global AI In Animal Health market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Inc., IDEXX Laboratories, Inc., Merck Animal Health, Heska Corporation, Microsoft Corporation, IBM Corporation, VCA Animal Hospitals (Mars, Inc.), IVC Evidensia, PrecisionHawk, Connecterra. The AI In Animal Health market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the AI In Animal Health industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth AI In Animal Health Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by AI In Animal Health companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional AI In Animal Health markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

AI In Animal Health Market Competitive Benchmarking and Company Analysis

Leading companies in AI In Animal Health industry include- Zoetis Inc., IDEXX Laboratories, Inc., Merck Animal Health, Heska Corporation, Microsoft Corporation, IBM Corporation, VCA Animal Hospitals (Mars, Inc.), IVC Evidensia, PrecisionHawk, Connecterra. The AI In Animal Health market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US AI In Animal Health Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the AI In Animal Health market remains one of the strongest-performing segments in the country.
The US AI In Animal Health Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US AI In Animal Health market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across AI In Animal Health industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian AI In Animal Health markets

Canada's strong AI In Animal Health sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian AI In Animal Health market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany AI In Animal Health Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest AI In Animal Health market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of AI In Animal Health population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany AI In Animal Health industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the AI In Animal Health market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support AI In Animal Health sales through 2034

France AI In Animal Health companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK AI In Animal Health Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of AI In Animal Health distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China AI In Animal Health Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China AI In Animal Health market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of AI In Animal Health industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese AI In Animal Health industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India AI In Animal Health Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian AI In Animal Health market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil AI In Animal Health market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa AI In Animal Health Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

AI In Animal Health Market Segmentation

By Component
Hardware
Software
Services
By Application
Diagnostics & Pathology
Identification, Tracking & Behavior Monitoring
Predictive Health Analytics & Disease Forecasting
Veterinary Practice Management & Telehealth
By Animal Type
Companion Animals
Production / Livestock Animals
By End-User
Veterinary Hospitals & Referral Centers
Private Veterinary Clinics
Commercial Farms & Livestock Producers
Academic & Research Institutions

Top Companies in AI In Animal Health Industry

Zoetis Inc.
IDEXX Laboratories, Inc.
Merck Animal Health
Heska Corporation
Microsoft Corporation
IBM Corporation
VCA Animal Hospitals (Mars, Inc.)
IVC Evidensia
PrecisionHawk
Connecterra

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025